PENICILLIN G POTASSIUM Drug Patent Profile
✉ Email this page to a colleague
When do Penicillin G Potassium patents expire, and when can generic versions of Penicillin G Potassium launch?
Penicillin G Potassium is a drug marketed by Mylan, Purepac Pharm, Acs Dobfar Spa, Apothecon, Consolidated Pharm, Hq Speclt Pharma, Istituto Bio Ita Spa, Lilly, Parke Davis, Pfizer, Sandoz, Watson Labs Inc, Ivax Sub Teva Pharms, Teva, Wyeth Ayerst, and Baxter Hlthcare. and is included in twenty-one NDAs.
The generic ingredient in PENICILLIN G POTASSIUM is penicillin g potassium. There are ninety-two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the penicillin g potassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Penicillin G Potassium
A generic version of PENICILLIN G POTASSIUM was approved as penicillin g potassium by SANDOZ on August 30th, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PENICILLIN G POTASSIUM?
- What are the global sales for PENICILLIN G POTASSIUM?
- What is Average Wholesale Price for PENICILLIN G POTASSIUM?
Summary for PENICILLIN G POTASSIUM
US Patents: | 0 |
Applicants: | 16 |
NDAs: | 21 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 71 |
Clinical Trials: | 4 |
Patent Applications: | 1,497 |
Drug Prices: | Drug price information for PENICILLIN G POTASSIUM |
What excipients (inactive ingredients) are in PENICILLIN G POTASSIUM? | PENICILLIN G POTASSIUM excipients list |
DailyMed Link: | PENICILLIN G POTASSIUM at DailyMed |
Recent Clinical Trials for PENICILLIN G POTASSIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Alphacait, LLC | Phase 2 |
Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
Phillip Brian Smith | Phase 1 |
Pharmacology for PENICILLIN G POTASSIUM
Drug Class | Penicillin-class Antibacterial |